Organon Pharma Indonesia Tbk. vs Sampoerna Agro Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Sampoerna Agro Tbk. trades at Rp4,790 (market cap 8.78T, 48.3K 24h volume). The key difference: Sampoerna Agro Tbk. is far larger — about 84.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SGRO | |
|---|---|---|
Market Cap | 104.4B | 8.78T |
Volume | — | 48.3K |
Lot | — | 483 |
Turnover | — | 231.32M |
Average Price | — | 4,789.32 |
Value | — | 231.32M |
Indicative Equilibrium Price | — | 4,790 |
Indicative Equilibrium Volume | — | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →Sampoerna Agro, PT (the company) was established under its original name of PT Selapan Jaya on Jun 7, 1993. The Company’s articles of association has been amended several times, concerning among others, the change in the Company’s name and public offering of stock.
Read more on SGRO →